ZA200808017B - Tetrahydropyridothienopyrimidine compounds and methods of use thereof - Google Patents
Tetrahydropyridothienopyrimidine compounds and methods of use thereofInfo
- Publication number
- ZA200808017B ZA200808017B ZA200808017A ZA200808017A ZA200808017B ZA 200808017 B ZA200808017 B ZA 200808017B ZA 200808017 A ZA200808017 A ZA 200808017A ZA 200808017 A ZA200808017 A ZA 200808017A ZA 200808017 B ZA200808017 B ZA 200808017B
- Authority
- ZA
- South Africa
- Prior art keywords
- tetrahydropyridothienopyrimidine
- compounds
- methods
- tetrahydropyridothienopyrimidine compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US78414606P | 2006-03-20 | 2006-03-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200808017B true ZA200808017B (en) | 2009-11-25 |
Family
ID=38523058
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200808017A ZA200808017B (en) | 2006-03-20 | 2008-09-18 | Tetrahydropyridothienopyrimidine compounds and methods of use thereof |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US8501755B2 (fr) |
| EP (1) | EP2001890B1 (fr) |
| JP (1) | JP5282026B2 (fr) |
| KR (1) | KR20080110834A (fr) |
| CN (1) | CN101448840B (fr) |
| AR (1) | AR059901A1 (fr) |
| AT (1) | ATE495179T1 (fr) |
| AU (1) | AU2007227317A1 (fr) |
| BR (1) | BRPI0711045A2 (fr) |
| CA (1) | CA2647036C (fr) |
| CR (1) | CR10304A (fr) |
| DE (1) | DE602007011906D1 (fr) |
| DO (1) | DOP2007000053A (fr) |
| EC (1) | ECSP088749A (fr) |
| ES (1) | ES2357654T3 (fr) |
| GT (1) | GT200800187A (fr) |
| IL (1) | IL194028A0 (fr) |
| MA (1) | MA30351B1 (fr) |
| MX (1) | MX2008012006A (fr) |
| NZ (1) | NZ571326A (fr) |
| PA (1) | PA8719401A1 (fr) |
| PE (1) | PE20080144A1 (fr) |
| RU (1) | RU2008141239A (fr) |
| SV (1) | SV2008003032A (fr) |
| TN (1) | TNSN08370A1 (fr) |
| TW (1) | TW200804397A (fr) |
| UY (1) | UY30220A1 (fr) |
| WO (1) | WO2007109279A2 (fr) |
| ZA (1) | ZA200808017B (fr) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2431927B (en) | 2005-11-04 | 2010-03-17 | Amira Pharmaceuticals Inc | 5-Lipoxygenase-activating protein (FLAP) inhibitors |
| US7977359B2 (en) | 2005-11-04 | 2011-07-12 | Amira Pharmaceuticals, Inc. | 5-lipdxygenase-activating protein (FLAP) inhibitors |
| US8399666B2 (en) | 2005-11-04 | 2013-03-19 | Panmira Pharmaceuticals, Llc | 5-lipoxygenase-activating protein (FLAP) inhibitors |
| CA2699349C (fr) * | 2007-09-14 | 2016-04-19 | Bayer Schering Pharma Aktiengesellschaft | Composes heterocycliques tricycliques substitues utilises comme inhibiteurs egfr |
| CN102137858B (zh) | 2008-05-23 | 2014-07-23 | 潘米拉制药有限责任公司 | 5-脂氧合酶-活化蛋白抑制剂 |
| TWI385174B (zh) * | 2008-11-10 | 2013-02-11 | Nat Health Research Institutes | 作為酪胺酸激酶抑制劑之稠合雙環及多環嘧啶化合物 |
| EP2806876A4 (fr) * | 2012-01-25 | 2016-03-02 | Proteostasis Therapeutics Inc | Composés renforçant l'activité des protéasomes |
| JP2017519737A (ja) * | 2014-05-26 | 2017-07-20 | バイエル・ファルマ・アクティエンゲゼルシャフト | 置換テトラヒドロピリドチエノピリミジン |
| US10561749B2 (en) | 2015-07-03 | 2020-02-18 | Kyoto University | Nuclear medicine diagnostic imaging agent |
| EP4186910A1 (fr) | 2016-06-22 | 2023-05-31 | Vanderbilt University | Modulateurs allostériques positifs du récepteur muscarinique de l'acétylcholine m4 |
| WO2018085803A1 (fr) | 2016-11-07 | 2018-05-11 | Vanderbilt University | Modulateurs allostériques positifs du récepteur muscarinique à l'acétylcholine m4 |
| JP7099725B2 (ja) | 2016-11-07 | 2022-07-12 | ヴァンダービルト ユニヴァーシティ | ムスカリン性アセチルコリンレセプターｍ４のポジティブアロステリック調節因子 |
| MA46899A (fr) | 2016-11-07 | 2021-04-14 | Univ Vanderbilt | Modulateurs allostériques positifs du récepteur muscarinique de l'acétylcholine m4 |
| TW201930311A (zh) | 2017-12-05 | 2019-08-01 | 泛德比爾特大學 | 蕈毒鹼型乙醯膽鹼受體m4之正向別構調節劑 |
| EP3720859A1 (fr) | 2017-12-05 | 2020-10-14 | Vanderbilt University | Modulateurs allostériques positifs du récepteur muscarinique de l'acétylcholine m4 |
| US20220177488A1 (en) * | 2019-03-19 | 2022-06-09 | Suvalent Therapeutics, Inc. | Sumo inhibitor compounds and uses thereof |
| WO2023015240A1 (fr) * | 2021-08-05 | 2023-02-09 | Bristol-Myers Squibb Company | Composés pyrimidines fusionnés tricycliques destinés à être utilisés en tant qu'inhibiteurs de her2 |
| CN114736154B (zh) * | 2022-03-15 | 2023-07-21 | 安庆朗坤药业有限公司 | N-（3-氯-4-（2-吡啶甲氧基）苯基）-2-氰基乙酰胺的制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1346358A (zh) * | 1999-03-30 | 2002-04-24 | 日本曹达株式会社 | 噻吩并嘧啶化合物及其盐和制备方法 |
| DE19944604A1 (de) | 1999-09-17 | 2001-03-22 | Merck Patent Gmbh | Aminderivate |
| US6608053B2 (en) * | 2000-04-27 | 2003-08-19 | Yamanouchi Pharmaceutical Co., Ltd. | Fused heteroaryl derivatives |
| WO2003035653A1 (fr) * | 2001-10-26 | 2003-05-01 | Nippon Soda Co.,Ltd. | Compose pyridothienopyrimidine et son sel |
| ES2280040T3 (es) | 2003-07-24 | 2007-09-01 | Bayer Pharmaceuticals Corporation | Compuestos de tetrahidrobenzotienopirimidinamina sustituidos utiles para tratar trastornos hiperproliferativos. |
-
2007
- 2007-03-15 AR ARP070101057A patent/AR059901A1/es not_active Application Discontinuation
- 2007-03-19 UY UY30220A patent/UY30220A1/es not_active Application Discontinuation
- 2007-03-19 PE PE2007000292A patent/PE20080144A1/es not_active Application Discontinuation
- 2007-03-19 TW TW096109309A patent/TW200804397A/zh unknown
- 2007-03-20 RU RU2008141239/04A patent/RU2008141239A/ru not_active Application Discontinuation
- 2007-03-20 KR KR1020087025480A patent/KR20080110834A/ko not_active Application Discontinuation
- 2007-03-20 AT AT07753547T patent/ATE495179T1/de not_active IP Right Cessation
- 2007-03-20 DO DO2007000053A patent/DOP2007000053A/es unknown
- 2007-03-20 WO PCT/US2007/006927 patent/WO2007109279A2/fr active Application Filing
- 2007-03-20 CN CN2007800178021A patent/CN101448840B/zh not_active Expired - Fee Related
- 2007-03-20 NZ NZ571326A patent/NZ571326A/en not_active IP Right Cessation
- 2007-03-20 BR BRPI0711045-6A patent/BRPI0711045A2/pt not_active IP Right Cessation
- 2007-03-20 EP EP07753547A patent/EP2001890B1/fr not_active Not-in-force
- 2007-03-20 PA PA20078719401A patent/PA8719401A1/es unknown
- 2007-03-20 CA CA2647036A patent/CA2647036C/fr not_active Expired - Fee Related
- 2007-03-20 US US12/225,285 patent/US8501755B2/en not_active Expired - Fee Related
- 2007-03-20 AU AU2007227317A patent/AU2007227317A1/en not_active Abandoned
- 2007-03-20 JP JP2009501517A patent/JP5282026B2/ja not_active Expired - Fee Related
- 2007-03-20 ES ES07753547T patent/ES2357654T3/es active Active
- 2007-03-20 MX MX2008012006A patent/MX2008012006A/es active IP Right Grant
- 2007-03-20 DE DE602007011906T patent/DE602007011906D1/de active Active
-
2008
- 2008-09-11 IL IL194028A patent/IL194028A0/en unknown
- 2008-09-18 SV SV2008003032A patent/SV2008003032A/es not_active Application Discontinuation
- 2008-09-18 GT GT200800187A patent/GT200800187A/es unknown
- 2008-09-18 ZA ZA200808017A patent/ZA200808017B/xx unknown
- 2008-09-19 CR CR10304A patent/CR10304A/es not_active Application Discontinuation
- 2008-09-19 EC EC2008008749A patent/ECSP088749A/es unknown
- 2008-09-22 TN TNP2008000370A patent/TNSN08370A1/en unknown
- 2008-10-20 MA MA31320A patent/MA30351B1/fr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL196956A0 (en) | Aza-benzofuranyl compounds and methods of use | |
| EP2023718A4 (fr) | Composés de ligand de créatine et procédés d'utilisation correspondants | |
| IL197060A0 (en) | Aza-benzothiophenyl compounds and methods of use | |
| ZA200808017B (en) | Tetrahydropyridothienopyrimidine compounds and methods of use thereof | |
| IL198397A0 (en) | Anilinopiperazine derivatives and methods of use thereof | |
| HK1147254A1 (en) | 5-anilinoimidazopyridines and methods of use 5- | |
| EP2094085A4 (fr) | Composés anti-cholestérolémiants et procédés d'utilisation | |
| GB0718972D0 (en) | Compounds and methods of making the compounds | |
| HK1135099A1 (en) | Aza-indolyl compounds and methods of use | |
| IL193693A0 (en) | Purine compounds and methods of use thereof | |
| EP2021555A4 (fr) | Élément structurel et procédés d'utilisation associés | |
| IL185309A0 (en) | Isoqunoline compounds and methods of use thereof | |
| IL206125A0 (en) | Azaindolizines and methods of use | |
| GB0611115D0 (en) | Compounds and their use | |
| IL192564A0 (en) | Composition and method of use thereof | |
| EP2069371A4 (fr) | Composés d'organo-arsénoxydes et leur utilisation | |
| ZA200900896B (en) | Aza-benzofuranyl compounds and methods of use | |
| ZA201004894B (en) | Nuctraceutical composition and methods of use | |
| IL192820A0 (en) | Novel compounds and use thereof | |
| ZA200901009B (en) | Aza-benzothiophenyl compounds and methods of use | |
| ZA201004893B (en) | Nuctraceutical composition and methods of use | |
| IL192552A0 (en) | Dnt-succinate and methods of preparation thereof | |
| ZA200807956B (en) | Purine compounds and methods of use thereof | |
| ZA200710971B (en) | Elasmobranch-repelling compounds and methods of use | |
| AU2006907075A0 (en) | Compounds and Methods of Use |